Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
Titel:
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
Auteur:
Wistinghausen, Birte Toner, Keri Barkauskas, Donald A. Jerkins, Lauren P Kinoshita, Hannah Chansky, Pamela Pezzella, Gloria Saguilig, Lauren Hayashi, Robert J. Abhyankar, Harshal Scull, Brooks Karri, Vivekanudeep Tanna, Jay Hanley, Patrick Hermiston, Michelle L. Allen, Carl E. Bollard, Catherine M.